References
- MillerDMVedulaASFlynnHWJrEndophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomesOphthalmic Surg Lasers Imaging20073844645118050805
- Endophthalmitis Vitrectomy Study GroupMicrobiologic factors and visual outcomes in the Endophthalmitis Vitrectomy StudyAm J Ophthalmol19961228308468956638
- Endophthalmitis Vitrectomy Study GroupResults of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitisArch Ophthalmol199511312147914967487614
- LibrePDella-LattaPChinNIntracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic modelJ Cataract Refract Surg2003291791179414522303
- DoftBHKelseySFWisniewskiSRThe EVS study groupAdditional procedures after the initial vitrectomy or tap-biopsy in the endophthalmitis vitrectomy studyOphthalmology19981057077169544646
- HariprasadSMMielerWFHolzERVitreous and aqueous penetration of orally administered gatifloxacin in humansArch Ophthalmol200412134535012617704
- HariprasadSMShahGKMielerWFVitreous and aqueous penetration of orally administered moxifloxacin in humansArch Ophthalmol200612417818216476886
- Park-WyllieLYJuurlinkDNKoppAOutpatient gatifloxacin and dysglycemia in older adultsN Engl J Med20063541352136116510739